A pooled analysis of adjusted outcomes from the available studies indicated that MINOCA and MI-CAD patients have similar long-term all-cause mortality risk. Our conclusions on the risk of cardiovascular mortality, MACE and readmission rates need to be taken with caution due to a lack of adequate studies. Further research is needed to strengthen the evidence on this important subject.
Keyphrases
- coronary artery disease
- end stage renal disease
- cardiovascular events
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- percutaneous coronary intervention
- peritoneal dialysis
- risk factors
- randomized controlled trial
- cardiovascular disease
- coronary artery bypass grafting
- big data
- open label
- placebo controlled